Drug discovery for TB: Targeting energy metabolism with TMC207
Event details
| Date | 18.03.2011 |
| Hour | 14:00 |
| Speaker | Dr. Anil Koul, Department of Antimicrobial Research, Johnson and Johnson, Belgium |
| Location | |
| Category | Conferences - Seminars |
Tuberculosis kills more people today than any other time in human history. TMC207 is currently in late stage clinical development for treatment of multi-drug resistant (MDR) tuberculosis. This presentation will give you an overall update on TMC207 and address some of the key questions on how to identify and discover new TB drugs.
Practical information
- General public
- Free
Organizer
- Dr. Neeraj Dhar
Contact
- Dr. Neeraj Dhar